Amitesh Roy

Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease?

Timothy Price, Carol Beeke, Shahid Ullah et al. · Cancer · 2014 · 166 citations · Full text

International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct

Sheela Rao, Francesco Sclafani, Cathy Eng et al. · Journal of Clinical Oncology · 2020 · 140 citations · Full text

A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma

Amitesh Roy, S. R. Park, David Cunningham et al. · Annals of Oncology · 2013 · 121 citations · Full text

Esophageal Cancer, Gastrointestinal Oncology, Gastro-oesophageal Junction Adenocarcinoma +10

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma

Victoria Atkinson, Adnan Khattak, Andrew Haydon et al. · Journal for ImmunoTherapy of Cancer · 2020 · 106 citations · Full text

Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival

David H. Murray, Erin L. Symonds, Graeme P. Young et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 52 citations · Full text

Residual Disease, Surgical Oncology, Oncology +11